“What is happening with chemistry in America?” queries Matthew D. Hall, a biology group leader at the US National Center for Advancing Translational Sciences (NCATS) in a Twitter post July 8. “We’re ...
On the pages of the calendar, it wasn’t too long ago that the thought of synthetic messenger RNA (mRNA) vaccines seemed quite imaginary to students in the Biotechnology Program at Thomas Jefferson ...
Are ADCs having a moment? Is CAR-T safe? And who’s to blame for failed trials? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. We discuss why AbbVie is spending $10 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results